RESULTS The efficacy rates of etamsylate, carbazochrome, hemocoagulase atrox and hemocoagulase were 62%, 65%, 83% and 85%, while the cost-benefit ratios of them were 51, 55, 39 and 39, respectively.

• 结果酚磺乙胺、卡络磺钠、血凝酶和白眉蛇毒血凝酶的有效率分别为62%25、65%25、83%25和85%25；费用-效益比分别为51、55、39和39。